◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY
Home › All stocks › ROIV › Operating Income

Roivant Sciences Ltd. (ROIV) Operating Income 2022–2026

DATA UPDATED 2026-07-10

Roivant Sciences Ltd. annual operating income for fiscal 2026 was -$1.3 billion, a decrease of 15.4% from -$1.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

ROIV Annual Operating Income

Operating Income (annual)2026-03-312025-03-312024-03-312023-03-312022-03-31
Operating Income (EBIT)($1.3B)($1.1B)($825M)($809M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ROIV Quarterly Operating Income

Operating Income (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Income (EBIT)($355M)($339M)($306M)($285M)($285M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More ROIV metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow

All ROIV financial statements → Interactive ROIV charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.